Last quarter (Q4 2023), Amphastar Pharmaceuticals's total revenue was $178.10M, an increase of 31.91% from the same quarter last year. In Q4, Amphastar Pharmaceuticals's net income was $36.17M. See Amphastar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 571.42M	$ 644.39M	$ 498.99M	$ 437.77M	$ 349.85M	$ 322.36M
Cost of Revenue	$ 83.08M	$ 18.80M	$ 17.20M	$ -238.03M	$ 206.51M	$ 190.43M
Gross Profit	$ 351.12M	$ 351.12M	$ 248.86M	$ 199.74M	$ 143.34M	$ 131.92M
Operating Expense	$ 154.13M	$ 154.13M	$ 141.36M	$ -129.85M	$ 132.39M	$ 131.96M
Operating Income	$ 196.99M	$ 196.99M	$ 107.50M	$ 69.89M	$ 10.95M	$ -39.00K
Net Non Operating Interest Income Expense	$ -21.70M	$ -21.70M	$ -525.00K	$ -284.00K	$ 268.00K	$ 878.00K
Other Income Expense	$ 5.91M	$ 5.91M	$ -7.89M	$ -14.33M	$ -6.58M	$ 59.39M
Pretax Income	$ 170.27M	$ 171.36M	$ 116.04M	$ 84.14M	$ 4.64M	$ 60.23M
Tax Provision	$ 31.83M	$ 31.83M	$ 23.48M	$ 20.63M	$ 3.54M	$ 13.72M
Earnings From Equity Interest Net Of Tax	$ -1.98M	$ -1.98M	$ -1.18M	$ -208.00K	$ 0.00	-
Net Income Common Stockholders	$ 137.54M	$ 137.54M	$ 91.39M	$ 62.12M	$ 1.40M	$ 48.94M
Basic EPS	-	-	-	-	$ 0.03	$ 1.04
Diluted EPS	-	-	-	-	$ 0.03	$ 0.98
Basic Average Shares	-	-	-	-	$ 47.04M	$ 46.98M
Diluted Average Shares	-	-	-	-	$ 49.12M	$ 49.91M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	$ 0.67	$ 0.38
Reported Normalized Diluted E P S	-	-	-	-	$ 0.64	$ 0.36
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 237.22M	$ 172.93M	$ -391.49M	$ -367.88M	$ 338.89M	$ 322.40M
Net Income From Continuing And Discontinued Operation	$ 137.54M	$ 137.54M	$ 91.39M	$ 62.12M	$ 1.40M	$ 48.94M
Normalized Income	$ 111.32M	$ 138.07M	-	-	$ 1.40M	$ 48.94M
Interest Expense	-	-	-	-	$ 374.00K	$ 119.00K
EBIT	$ 197.43M	$ 198.52M	$ 117.89M	$ 85.02M	$ 5.01M	$ 60.35M
EBITDA	$ 250.60M	$ 251.69M	$ 146.61M	$ 111.78M	$ 30.19M	$ 81.47M

Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing